News

Pfizer and BioNTech announced Tuesday that they have filed an application to the US Food and Drug Administration for urgent use permission of an extra booster dose of their COVID-19 vaccine for adults 65 or older who have already...

Biogen Inc. announced that the companies have amended their existing collaboration agreement on aducanumab, which is commercialized in the United States as ADUHELM. Effective as of January 1, 2023, Eisai will receive a tiered royalty based on net sales...

OcyonBio announces manufacturing and operations agreement to develop biosimilar drug product facilities for Biosimilar Solutions, Inc. OcyonBio is creating an advanced therapy contract development, manufacturing organization (CDMO) that provides pre-clinical through commercial manufacturing including process development, plasmid DNA, viral...

A German independent research institute, BioMed X, announces  the start of its new research project ‘Regulatory T Cell Dysfunction in Autoimmunity and Inflammaging’ (TDA) in collaboration with Merck KGaA, Darmstadt, Germany. The main objective of the research group TDA...

The FDA approved the AstraZeneca and Merck medications for a select subset of individuals with severe early-stage breast cancer, after chemotherapy before or after surgery. The patient's tumour must have BRCA mutations in the germline and be HER2-negative. According to...

On May 17th, 500+ of pharma’s clinical innovation will come together for the home of clinical collaboration, Reuters Events: Pharma Clinical 2022,to set new standards in digital and patient innovation for clinical transformation. The catalyst for this has been the...

Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, announced that it has acquired Casimir, a U.S.-based CRO. Casimir has experience in more than 20 rare diseases and has...